Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Italian guidelines in diagnosis and treatment of alopecia areata.

Rossi A, Muscianese M, Piraccini BM, Starace M, Carlesimo M, Mandel VD, Alessandrini A, Calvieri S, Caro G, D'arino A, Federico A, Magri F, Pigliacelli F, Amendolagine G, Annunziata MC, Arisi MC, Babino G, Bardazzi F, Barruscotti S, Belloni Fortina A, Borghi A, Bruni F, Caccavale S, Calzavara Pinton P, Cameli N, Carugno A, Coppola R, Dattola A, De Felici Del Giudice MB, Di Cesare A, Dika E, D'ovidio R, Fabbrocini G, Feliciani C, Fulgione E, Galluzzo M, Garcovich S, Garelli V, Guerriro C, Hansel K, La Placa M, Lacarrubba F, Lora V, Marinello E, Megna M, Micali G, Misciali C, Monfrecola G, Neri I, Offidani A, Orlando G, Papini M, Patrizi A, Piaserico S, Rivetti N, Simonetti O, Stan TR, Stingeni L, Talamonti M, Tassone F, Villa L, Vincenzi C, Fortuna MC.

G Ital Dermatol Venereol. 2019 Sep 26. doi: 10.23736/S0392-0488.19.06458-7. [Epub ahead of print]

PMID:
31578836
2.

Pectus excavatum in neurofibromatosis type 1: single-center experience and review of the literature.

Miraglia E, Chello C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Sep 26. doi: 10.23736/S0392-0488.19.06456-3. [Epub ahead of print] No abstract available.

PMID:
31578835
3.

Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma".

Curioni-Fontecedro A, Pitocco R, Schoenewolf NL, Holzmann D, Soldini D, Dummer R, Calvieri S, Moch H, Fitsche A, Mihic-Probst D.

Biomed Res Int. 2019 Jul 22;2019:5256364. doi: 10.1155/2019/5256364. eCollection 2019.

4.

MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.

Valentini V, Zelli V, Gaggiano E, Silvestri V, Rizzolo P, Bucalo A, Calvieri S, Grassi S, Frascione P, Donati P, Soda G, Ottini L, Richetta AG.

Anticancer Res. 2019 Aug;39(8):4085-4093. doi: 10.21873/anticanres.13566.

PMID:
31366492
5.

Lichen sclerosus and Sjögren's syndrome: two case reports.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Jul 26. doi: 10.23736/S0392-0488.19.06362-4. [Epub ahead of print] No abstract available.

PMID:
31355618
6.

Regression of benign melanocytic nevi ipilimumab-induced in an adult patient affected by metastatic melanoma: is it a sign of response to therapy?

Grassi S, Corsetti P, Moliterni E, Calvieri S.

G Ital Dermatol Venereol. 2019 May 14. doi: 10.23736/S0392-0488.19.06351-X. [Epub ahead of print] No abstract available.

PMID:
31104465
7.

Effectiveness of oral propranolol in a patient with neurofibromatosis type 1 and infantile hemangiomas.

Miraglia E, Schiavetti A, Varrasso G, Celli M, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Mar 29. doi: 10.23736/S0392-0488.19.06179-0. [Epub ahead of print] No abstract available.

PMID:
30924624
8.

A case of Cowden syndrome associated with melanoma: the role of the dermatologist.

Roberti V, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Feb 4. doi: 10.23736/S0392-0488.19.06272-2. [Epub ahead of print] No abstract available.

PMID:
30717572
9.

Melanoma in neurofibromatosis type 1: an Italian single center experience.

Miraglia E, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Feb;154(1):89-91. doi: 10.23736/S0392-0488.17.05612-7. No abstract available.

PMID:
30616334
10.

Correlation of serum tryptase levels with total number of nevi, Breslow thickness, ulceration, and mitotic index in melanoma patients: evaluation of a promising prognostic marker.

Crincoli E, Moliterni E, Catania F, Didona D, Calvieri S, Paolino G.

Melanoma Res. 2019 Dec;29(6):621-625. doi: 10.1097/CMR.0000000000000561.

PMID:
30557216
11.

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas.

Paolino G, Didona D, Scarnò M, Tallarico M, Cantoresi F, Calvieri S, Mercuri SR, Piccolo D, Bottoni U, Kyriakou A, Cantisani C.

Dermatol Ther. 2019 Mar;32(2):e12788. doi: 10.1111/dth.12788. Epub 2018 Dec 21. No abstract available.

PMID:
30499211
12.

Lipomas in Neurofibromatosis Type 1: a single-institution experience.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 22. doi: 10.23736/S0392-0488.18.06044-3. [Epub ahead of print] No abstract available.

PMID:
30350556
13.

Two rare disease in the same patient: neurofibromatosis type 1 and Madelung's disease.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06166-7. [Epub ahead of print] No abstract available.

PMID:
30295449
14.

Nevus spilus in neurofibromatosis type 1: a single center experience.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06088-1. [Epub ahead of print] No abstract available.

PMID:
30295445
15.

Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report.

Grieco T, Chello C, Faina V, Gomes VV, Alei L, Sernicola A, Panasiti V, Calvieri S.

J Dermatolog Treat. 2018;29(sup3):10-13. doi: 10.1080/09546634.2018.1527990.

PMID:
30256692
16.

Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.

Cantisani C, Paolino G, Scarnò M, Didona D, Tallarico M, Moliterni E, Losco L, Cantoresi F, Mercuri SR, Bottoniτ U, Calvieri S.

Dermatol Ther. 2018 Nov;31(6):e12710. doi: 10.1111/dth.12710. Epub 2018 Sep 25. No abstract available.

PMID:
30253027
17.

Giant plexiform neurofibroma in neurofibromatosis type 1.

Miraglia E, Lopez T, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct;153(5):740-741. doi: 10.23736/S0392-0488.17.05678-4. No abstract available.

PMID:
30246960
18.

Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.

Moliterni E, Paolino G, Veronese N, Bottoni U, Corsetti P, Cardone M, Didona D, Lopez T, Calvieri S.

G Ital Dermatol Venereol. 2018 Oct;153(5):732-733. doi: 10.23736/S0392-0488.17.05652-8. No abstract available.

PMID:
30246955
19.

Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile.

Richetta AG, Valentini V, Marraffa F, Paolino G, Rizzolo P, Silvestri V, Zelli V, Carbone A, Di Mattia C, Calvieri S, Frascione P, Donati P, Ottini L.

Oncotarget. 2018 Aug 14;9(63):32173-32181. doi: 10.18632/oncotarget.25864. eCollection 2018 Aug 14.

20.

Neurodystrophic Hand Dermatitis: Sannino Barduagni Syndrome.

Bottoni U, Tamburrini S, Scali E, Dastoli S, Amoruso GF, Paolino G, Moliterni E, Grieco T, Pranteda G, Calvieri S.

Acta Dermatovenerol Croat. 2017 Dec;25(4):312-313.

PMID:
30064610
21.

PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report.

Valentini V, Zelli V, Rizzolo P, Silvestri V, Alimandi M, D'Aloia MM, Giustini S, Calvieri S, Richetta AG, Monteleone G, Ottini L.

Clin Case Rep. 2018 Jun 2;6(7):1358-1363. doi: 10.1002/ccr3.1546. eCollection 2018 Jul.

22.

Pseudoxanthoma elasticum in Italy: epidemiological and clinical aspects.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun 29. doi: 10.23736/S0392-0488.18.06076-5. [Epub ahead of print] No abstract available.

PMID:
29963809
23.

Lipomatosis of the caregiver: a new form of cutaneous lipomatosis.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun 29. doi: 10.23736/S0392-0488.18.06055-8. [Epub ahead of print] No abstract available.

PMID:
29963805
24.

Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.

Neri L, Peris K, Longo C, Calvieri S, Frascione P, Parodi A, Eibenschuz L, Bottoni U, Pellacani G; Actinic Keratosis - TReatment Adherence INitiative (AK-TRAIN) study group.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):93-107. doi: 10.1111/jdv.15142. Epub 2018 Jul 8.

PMID:
29920789
25.

Nasopharyngeal Melanoma.

Paolino G, Didona D, Macrì G, Calvieri S, Mercuri SR.

In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 4.

26.

Anorectal Melanoma.

Paolino G, Didona D, Macrì G, Calvieri S, Mercuri SR.

In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 6.

27.

Poliosis circumscripta in association with neurofibromatosis type 1: only a coincidence?

Miraglia E, Roberti V, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 May 16. doi: 10.23736/S0392-0488.18.05882-0. [Epub ahead of print] No abstract available.

PMID:
29781260
28.

Melanoma in female patients: general features and focus on the impact of estro-progestinic pills in prognostic factors.

Paolino G, Moliterni E, Didona D, Corsetti P, Lopez T, Abbenante D, Calvieri S, Bottoni U.

G Ital Dermatol Venereol. 2018 Aug;153(4):582-585. doi: 10.23736/S0392-0488.17.05585-7. No abstract available.

PMID:
29767487
29.

Two sisters with neurofibromatosis type 1 and celiac disease.

Lopez T, Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun;153(3):444-446. doi: 10.23736/S0392-0488.17.05576-6. No abstract available.

PMID:
29766709
30.

Multiple granuloma faciale: a clinical finding from a dermoscopic point a view.

Pampena R, Paolino G, Didona D, Longo C, Salvi M, Giona F, Santopietro M, Carbone A, Frascione P, Calvieri S, Donati P.

G Ital Dermatol Venereol. 2018 Jun;153(3):439-440. doi: 10.23736/S0392-0488.17.05551-1. No abstract available.

PMID:
29766705
31.

Effectiveness of oral propranolol for infantile hemangiomas started after 5 months of age.

Lopez T, Miraglia E, Schiavetti A, Varrasso G, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 May 10. doi: 10.23736/S0392-0488.18.05958-8. [Epub ahead of print] No abstract available.

PMID:
29747482
32.

Multiple lipomas in a patient with Neurofibromatosis Type 1.

Miraglia E, Fino P, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Apr 19. doi: 10.23736/S0392-0488.18.05869-8. [Epub ahead of print] No abstract available.

PMID:
29683278
33.

Juvenile myelomonocytic leukemia in a patient with neurofibromatosis type 1 and xanthogranulomas.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Mar 29. doi: 10.23736/S0392-0488.18.05983-7. [Epub ahead of print] No abstract available.

PMID:
29600694
34.

Anticarcinogenic activities of sulforaphane are influenced by Nerve Growth Factor in human melanoma A375 cells.

Arcidiacono P, Stabile AM, Ragonese F, Pistilli A, Calvieri S, Bottoni U, Crisanti A, Spaccapelo R, Rende M.

Food Chem Toxicol. 2018 Mar;113:154-161. doi: 10.1016/j.fct.2018.01.051. Epub 2018 Jan 31.

PMID:
29407470
35.

HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes.

Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, Calvieri S, Gismondi A, Taramelli D, Dell'Agli M.

Mediators Inflamm. 2017;2017:7435621. doi: 10.1155/2017/7435621. Epub 2017 Dec 17.

36.

A new distal phenotype of Madelung's disease.

Miraglia E, Fino P, Iacovino C, Lopez T, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Jun;154(3):371-372. doi: 10.23736/S0392-0488.18.05760-7. Epub 2018 Jan 24. No abstract available.

PMID:
29368851
37.

Shagreen-patch in a NF1 patient with a new missense mutation.

Lopez T, Paolino G, Miraglia E, Iacovino C, De Luca A, Donati P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Apr;154(2):223-224. doi: 10.23736/S0392-0488.18.05724-3. Epub 2018 Jan 24. No abstract available.

PMID:
29368848
38.

Pruritus in neurofibromatosis type 1.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Feb;153(1):120-122. doi: 10.23736/S0392-0488.17.05457-8. No abstract available.

PMID:
29319283
39.

Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1.

Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Iacovino C, Calvieri S, Lambiase A.

Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):307-311. doi: 10.1007/s00417-017-3870-z. Epub 2017 Dec 30.

PMID:
29290016
40.

Vitamin D and melanoma: state of the art and possible therapeutic uses.

Paolino G, Moliterni E, Corsetti P, Didona D, Bottoni U, Calvieri S, Mattozzi C.

G Ital Dermatol Venereol. 2019 Feb;154(1):64-71. doi: 10.23736/S0392-0488.17.05801-1. Epub 2017 Dec 15. Review.

41.

Classification of cutaneous manifestations in patients with non-celiac gluten sensitivity (NCGS) and wheat allergy (WA).

Faina V, Paolino G, Bavastrelli M, Calvieri S, Grieco T.

J Am Acad Dermatol. 2017 Dec 13. pii: S0190-9622(17)32811-6. doi: 10.1016/j.jaad.2017.12.013. [Epub ahead of print] No abstract available.

PMID:
29246823
42.

Mast cells and cancer: a review of literature.

Paolino G, Corsetti P, Moliterni E, Corsetti S, Didona D, Albanesi M, Mattozzi C, Lido P, Calvieri S.

G Ital Dermatol Venereol. 2017 Nov 30. doi: 10.23736/S0392-0488.17.05818-7. [Epub ahead of print]

PMID:
29192477
43.

Severe adverse drug reaction due to cypress sublingual immunotherapy.

Grieco T, Paolino G, Faina V, Moliterni E, Carnicelli G, Bottoni U, Calvieri S.

G Ital Dermatol Venereol. 2019 Jun;154(3):367-368. doi: 10.23736/S0392-0488.17.05782-0. Epub 2017 Nov 30. No abstract available.

PMID:
29192473
44.

Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Paolino G, Didona D, Magliulo G, Iannella G, Didona B, Mercuri SR, Moliterni E, Donati M, Ciofalo A, Granata G, Ranuzzi P, Falasca V, Calvieri S.

Int J Mol Sci. 2017 Nov 26;18(12). pii: E2532. doi: 10.3390/ijms18122532. Review.

45.

Correlation between plasmatic levels of vitamin D and PASI score.

Mattozzi C, Paolino G, Salvi M, Macaluso L, Scarnò M, DE Vita G, Calvieri S, Richetta AG.

G Ital Dermatol Venereol. 2018 Apr;153(2):155-160. doi: 10.23736/S0392-0488.17.05622-X. Epub 2017 Nov 16.

PMID:
29144098
46.

Cutaneous lipomatosis: diagnosing a rare condition.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2017 Dec;152(6):678-680. doi: 10.23736/S0392-0488.16.05410-9. No abstract available.

PMID:
29050453
47.

Becker's nevus in neurofibromatosis type 1: a single center experience in Italy.

Miraglia E, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2017 Oct;152(5):545-547. doi: 10.23736/S0392-0488.16.05374-8. No abstract available.

PMID:
28906096
48.

Retinitis pigmentosa: an unusual ocular manifestation in a patient with neurofibromatosis type 1.

Miraglia E, Moramarco A, Bianchini D, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2017 Oct;152(5):543-544. doi: 10.23736/S0392-0488.16.05360-8. No abstract available.

PMID:
28906094
49.

Mast Cell Disorders, Melanoma and Pancreatic Carcinoma: From a Clinical Observation to a Brief Review of the Literature.

Paolino G, Belmonte M, Trasarti S, Santopietro M, Bizzoni L, Riminucci M, Cardarelli L, Iannella E, Albanesi M, Moliterni E, Didona D, Calvieri S, Foà R, Giona F.

Acta Dermatovenerol Croat. 2017 Jul;25(2):112-119. Review.

PMID:
28871925
50.

Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells.

Arcidiacono P, Ragonese F, Stabile A, Pistilli A, Kuligina E, Rende M, Bottoni U, Calvieri S, Crisanti A, Spaccapelo R.

Eur J Nutr. 2018 Oct;57(7):2547-2569. doi: 10.1007/s00394-017-1527-7. Epub 2017 Sep 1.

Supplemental Content

Loading ...
Support Center